Weekly Recap | Asymchem -3.42%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:42 AM06821-0.18%
G Sachs: Strong 3Q Orders for China's CRO and CDMO Firms Enhance Visibility for 2027AASTOCKS News·Nov 12, 2026 at 07:05 AM02359-0.84%03347-1.49%
Weekly Recap | Asymchem +19%, most brokers rate it buyWeekly Review·Nov 7, 2026 at 06:21 AM06821-0.18%
JPM: China's CDMO Sector Enters New Development Phase; Initiates Overweight on PHARMARON and ASYMCHEM H ShrsAASTOCKS News·Nov 6, 2026 at 07:03 AM03759-1.56%06821-0.18%
Asymchem climbs 6% on plan to buy back up to 700 million yuanMarket Movers·Nov 5, 2026 at 01:39 AM06821-0.18%
Asymchem Shareholders Approve Amendments to Articles at 2026 EGMTip Ranks·Oct 20, 2026 at 11:38 AM06821-0.18%002821+1.54%
Niche Plays Drive Hong Kong's Fringe Market as mRNA, Robotics Gain TractionGlobal Report·Oct 20, 2026 at 09:17 AM00389-3.70%00894-6.25%
Weekly Recap | Asymchem -11.85%, most brokers rate it buyWeekly Review·Oct 17, 2026 at 06:18 AM06821-0.18%
Hong Kong's long tail: special dividends, bitcoin piles and a currency squeezeGlobal Report·Oct 13, 2026 at 10:51 AM06186+1.23%00836-3.28%
Capacity Crunch and Compliance Crosshairs: Hong Kong's Hard Tech Firms in FluxGlobal Report·Oct 13, 2026 at 09:24 AM02631-2.96%00241-2.19%
Weekly Recap | Asymchem -7.24%, board date set ahead of Q3Weekly Review·Oct 10, 2026 at 05:45 AM06821-0.18%